{"id":447147,"date":"2019-11-13T03:36:03","date_gmt":"2019-11-13T03:36:03","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=447147"},"modified":"2019-11-13T03:36:03","modified_gmt":"2019-11-13T03:36:03","slug":"particle-therapy-market-2019-growth-potential-dynamics-global-size-analysis-reginal-outlook-and-demand-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/particle-therapy-market-2019-growth-potential-dynamics-global-size-analysis-reginal-outlook-and-demand-forecast-to-2023_447147.html","title":{"rendered":"Particle Therapy Market 2019 Growth Potential, Dynamics, Global Size Analysis, Reginal Outlook and Demand Forecast to 2023"},"content":{"rendered":"
\"Particle<\/a><\/p>\n
\n
Particle Therapy Market <\/div>\n<\/div>\n<\/div>\n
Market Research Future has starting late imparted another examination to its wide research portfolio, which is titled as \u201cParticle Therapy Market Research Report \u2013 Global Forecast till 2023″ gives an all-around examination the measure of market size and advancement\n<\/div>\n

Particle therapy is the most advanced areas of external beam radiation therapy applied to cancer treatment. This technique saves healthier tissue from radiation by using most advanced areas of external beam radiation therapy. The factors propelling the growth of the global particle therapy market are low risks from treatment-induced disorders, rising population of cancer patients, potential for retreatment owing to low radiation dose, and rising number of particle therapy centers across the world are expected to drive the growth of the market. However, the lack of adequate reimbursement policy and high costs involved in the establishment of these centers may hamper the growth of the market during the assessment period.<\/p>\n

Get Free Sample Copy @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/7000<\/em><\/a>     <\/em><\/p>\n

The global particle therapy market is accounted for USD 790.45 million in 2017 and expected to register 9.1% CAGR during the forecast period (2018–2023).<\/p>\n

In the Americas, the North American market is likely to hold the majority share of the particle therapy market owing to the rising number of particle center along with the growing cancer affected population, increasing funding by manufacturer, and government focused for establishment of centers for treatment. According to the Particle Therapy Co-Operative Group, Atlantic Health System, planning to open particle therapy center in New Jersey, NY by 2020. Also, Huntsman Cancer Institute, planning to open particle therapy center in USA by 2021. According to the International Agency for research on cancer, in 2018, around 1195.7 patient per 100,000 population are affected with cancer in United States.<\/p>\n

Segmentation:<\/strong><\/p>\n

The Global Particle Therapy Market has been segmented on the basis of type, product & service, cancer type, system, and application.On the basis of type, the market has been classified as proton therapy and heavy ion therapy. The market, by product and services, has been segmented into products and services. Products are further segmented into cyclotrons, synchrotrons, and synchrocyclotrons. Based on cancer type, the market has been segmented into prostate cancer, lung cancer, pediatric cancer, head and neck cancer, breast cancer, and others. The market, by system, has been segmented into multi-room systems and single-room systems. On the basis of application, the market has been classified as treatment applications and research applications. The pediatric cancer segment is expected to hold the largest market share of the particle therapy market, by cancer type, during the forecast period. Also, research applications to register the highest CAGR in the global particle therapy market during the forecast period.<\/p>\n

Top Key Players<\/strong><\/p>\n

Some of the key players in the global particle theraphy market are Advanced Oncotherapy PLC., Danfysik A\/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc.<\/p>\n

Browse Premium Research Report Enabled with Respective Tables and Figures <\/em><\/strong>@<\/em><\/strong>https:\/\/www.marketresearchfuture.com\/reports\/particle-therapy-market-7000<\/em><\/a><\/p>\n

About US:<\/strong><\/p>\n

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/particle-therapy-market-7000<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Particle Therapy Market Market Research Future has starting late imparted another examination to its wide research portfolio, which is titled as \u201cParticle Therapy Market Research Report \u2013 Global Forecast till 2023″ gives an all-around examination the measure of market size … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,404,416],"tags":[],"class_list":["post-447147","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/447147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=447147"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/447147\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=447147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=447147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=447147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}